Richard Furman, MD

Dr. Richard Furman is Director of the CLL Research Center at Weill Cornell Medicine, where he focuses on identifying new and promising therapies for patients with CLL. Along with collaborators at Columbia Presbyterian, Johns Hopkins, Roswell Park Cancer Institute, and Ohio State University, Dr. Furman has initiated the Waldenstrom's Research Consortium in order to enhance treatment and understanding of Waldenstrom's Macroglobulinemia.